Introduction
Onyx is a new liquid embolic system (Micro Therapeutics, Inc., Irvine, CA) consisting of ethylene-vinyl alcohol copolymer (EVOH), formed of 48 mol/L ethylene and 52 mol/L vinyl alcohol, dissolved in dimethyl-sulfoxide (DMSO) and mixed with micronized tantalum powder (35% weight per volume) for radiopaque visualization. In its low density form it is predominantly used worldwide in the treatment of cerebral [1] [2] [3] [4] [5] [6] or spinal 7, 8 arteriovenous malformations (AVMs), other more rare indications are hypervascularized tumors 9 , peripheral AVMs or arteriovenous fistulas (AVFs) 10 , and there is also an extensive use in experimental work [11] [12] . Onyx LD means low density of EVOH in the range of 6 to 8 % (Onyx 18 to 34) compared to high density Onyx 500 + (containing 20 % of EVOH) used for aneurysm occlusions. The basics of Onyx LD liquid system and the main principles of its application in endovascular AVM therapy are described and discussed in this chapter.
ed that even positioning the tip of the catheter just shortly below the level of the "nidus" in the feeding artery may lead to incomplete filling of the nidus, and that the volume and the extension of Onyx reflux is much higher than it is for intranidal positioning (figure 2).
The angioarchitecture of the malformation is a determining factor for EVOH concentration to be used. The viscosity of Onyx nearly doubles from Onyx LD 18 to 34, the numbers in Onyx 18,20 and 34 are related to the unit of centipoise, the hundreth of a poise, the unit of viscosity (1 poise=dyne sec/cm 2 or 1.0g/cm/sec). The main criteria for the choice of Onyx 18, 20 or 34 (concentration of EVOH of 6; 6,5 and 8%) are the distance from tip of the microcatheter to the venous part of the malformation, flow rate and fistulous versus plexiform appearance of the nidus. Nevertheless beside the clearly defined differences in the viscosity from Onyx 18 to 34, there is lack of experimental data for a rational selection of one or more of the substances. Our own ongoing studies using the rete mirabile of the swine under different flow conditions are promising to fill this gap. Actually, there is a widespread use of different Onyx densities, dependent on the investigator, and, at the moment, no precise or binding recommendations for the best choice are possible.
The first step in starting Onyx injection is normally to produce a plug around the tip of the catheter to establish and increase a pressure gradient to the distal part within the nidus, which is supported by pushing Onyx carefully into the nidal part of the malformation.
This so-called "plug and push" technique allows a complete occlusion of over 100 percent in the rete mirabile of the swine in experimental work, even if there is no arteriovenous shunt over the rete mirabile. The differences in the filling results using "plug and push" and other injection techniques are demonstrated in diagram 1.
The injection of Onyx is slow and ranges mostly between 0.1 and 0.2 ml per minute and should not exceed over 0.3 ml to maintain the microcatheter injection pressure at a safe level and to avoid vasospasm and angionecrosis. Care should be taken when injecting the initial drop of Onyx since the catheter is filled with pure DMSO.
The experimental data from Murayama et al, published in 1988 15 , clearly demonstrates that an excessively fast injection of DMSO during Onyx delivery increases the risk and safety of the application. When 0.5 ml of pure DMSO is injected in 30 to 120 seconds neither vasospasm nor any other complications are observed. Injection of the same volume within 5 to 15 seconds may lead to vasospasm and angionecrosis. These data were confirmed by Chaloupka et Al 16 and a long term follow-up study of 29 patients, who where observed over a period of up to 5 years after embolization, and showed neither cardiomyopathy nor neoplasms after the treatment using DMSO as an organic solvent 17 . Besides these safety aspects, fast injection speed only produces more reflux and with it increasing pressure within the catheter (diagram 2 A,B).
The extent of reflux is normally accepted from 1 to 2 cm, beyond this, according to animal experiments, an improvement of the embolization result can not be expected (diagram 3).
The Onyx application continues at intervals of injection and break phases, where the breaks normally last between 30 seconds and two minutes, depending on the volume and the time of the injection phase. The break should not exceed 2 to 3 minutes and can be dangerous after this period due to increasing pressure within the microcatheter with high risk of unintentional catheter tip occlusion (diagram 4). With the slow injection of Onyx, the breaks and the intranidal positioning of the microcatheter, a homogenous spongy polymeric cast is created ( figure 3 A,B) . The polymer solidifies from out- PSI to-inside. In figure 4 the injection pattern during the interventional session is illustrated. Summarizing the reasons for the necessity of the slow injection and the injection/break intervals of Onyx application, there is an increase of the angiotocixity with enhancing injection speed, an increase of the pressure within the microcatheter and the length of the produced reflux, as well as the disadvantage of obtaining inhomogenities of the spongic cast. 
Surgical Resection and Histopathological Examinations
Inflammatory reaction can be observed in the histopathological examination after resection of the AVM and preoperative endovascular embolization with ethylene vinyl alcohol copolymer. However, the imflammatory response to the nidal tissue is usually mild, especially compared to n-butyl 2 cyanoacrylate (NBCA). The common findings in the histopathological examination are a homogenous distribution of EVOH in the small nidal vessels. Tantalum is predominantly located at the wall of the vessels and red thrombus material is inconstantly found in the lumen. Although both, recanalization and ongoing thrombosis in angiographic controls after embolizations, as observed in clinical reports 18 , the vessel occlusion after embolization had to be defined as a permanent occlusion. Observation of angionecrosis in the specimens after surgical resection of the AVM is rare. For surgeon the resection seems to be easier to handle 19 because the Onyx cast is soft, formable and elastic 20 .
Withdrawal of the Microcatheter
Although the Onyx liquid embolic system is a nonadhesive agent, problems with the withdrawal of the microcatheter after the embolization can occur. This depends on the depth of the postioning of the microcatheter within the nidus, presence of loops in the feeding arteries and tortuosity of the intracranial vessels, the volume of Onyx and the injection time during the treatment session, and may be due to the occurrence of vasospasm. Our own experiences, personal communications with other interventional groups and company informations confirm that the problem of withdrawal of the microcatheter occur in less than 5 percent of all interventional sessions worldwide. This is a serious problem.
The influence of the length of the reflux produced during the embolization is one but not the most important factor of this problem. Special strategies have been developed to overcome this problem and growing experiences with Onyx reduce the risk. Now, there is a new microcatheter available, which is smaller (1.3 vs
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Begin Slow Onyx Injection Figure 4 Summary and illustration of the decision process during the Onyx injection from the beginning of the application in repeat and reinject cycles. 1.5 Fr), also flow-directed and braided in the distal part with nitinol. Our own first and limited experiences using this new microcatheter show that there are no problems of withdrawing the microcatheter and the procedure seems much easier. We hope that with this new microcatheter the "withdrawal" -problem is one of the past. Experimental data support this hope. There is less detachment force necessary to retrieve the new microcatheter and an increase of the tensile strength of the distal catheter tip in comparison of both flow directed microcatheters (Diagram 5 A,B).
Conclusions and Summary
Onyx LD liquid embolic system is a promising nonadhesive permanent occlusive agent for embolizing cerebral and spinal arteriovenous malformations. Compared to NBCA, the preparation, application and the behavior of the two substances is completely different. Only the learning curve to control the embolization of AVMs safely and effectively seems similar in both. Reducing this learning curve is the target of the described preparations and applications of Onyx LD.
